Sales of analgesics are expected to remain positive in Switzerland over the forecast period. The performance of analgesics will likely remain strongly linked with potential surges of other COVID-19 variants (or similar) over the forecast period.
Despite a positive forecast performance, analgesics is an OTC category that will likely reach maturity and saturation in the mid-term. Besides, a more careful usage of analgesics by many Swiss consumers, in the context of media coverage about their side-effects, will also limit further growth opportunities.
Talks about a potential distribution deregulation have been going on for years in Switzerland. If this succeeds, it will potentially pose a threat to growth in analgesics during the forecast period, as sales of those products will be authorised in supermarkets.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Analgesics industry in Switzerland with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Switzerland, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).See All of Our Definitions
This report originates from Passport, our Analgesics research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!